Reduced striatal dopamine transporter density associated with working memory deficits in opioid‐dependent male subjects: a SPECT study

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Addiction Biology

• Publication date

  2016-01-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1111/adb.12203PMID 25439653
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sex Differences in

  2016cited by this paper
• No difference in striatal dopamine transporter availability between active smokers, ex-smokers and non-smokers using [123I]FP-CIT (DaTSCAN) and SPECT

  2013cited by this paper
• Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment

  2013influential reference
• Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis.

  2012cited by this paper
• Voxel-based analysis of whole-brain effects of age and gender on dopamine transporter SPECT imaging in healthy subjects

  2012cited by this paper
• Opiate versus psychostimulant addiction: the differences do matter

  2011cited by this paper
• Availability of dopamine and serotonin transporters in opioid-dependent users—a two-isotope SPECT study

  2011influential reference
• Drug-related decrease in neuropsychological functions of abstinent drug users.

  2011cited by this paper
• Dopamine and serotonin transporter availability in chronic heroin users: a [¹²³I]β-CIT SPECT imaging study.

  2010influential reference
• Correlation between errors on the Wisconsin Card Sorting Test and the availability of striatal dopamine transporters in healthy volunteers.

  2010cited by this paper
• Neurocircuitry of Addiction

  2010cited by this paper
• The Wisconsin Card Sorting Test and the cognitive assessment of prefrontal executive functions: a critical update.

  2009influential reference
• The Neurobiology of Addictive Disorders

  2009cited by this paper
• Striatal dopamine and working memory.

  2009cited by this paper
• Adult Normative Data of the Wisconsin Card Sorting Test in Taiwan

  2008cited by this paper
• PET imaging of dopamine transporter and drug craving during methadone maintenance treatment and after prolonged abstinence in heroin users.

  2008influential reference
• Dopamine transporter mutant mice in experimental neuropharmacology

  2008cited by this paper
• Is opiate addiction associated with longstanding neurobiological changes?

  2007cited by this paper
• Heroin Abuse Is Characterized by Discrete Mesolimbic Dopamine and Opioid Abnormalities and Exaggerated Nuclear Receptor-Related 1 Transcriptional Decline with Age

  2007influential reference
• Phasic dysfunction of dopamine transmission in Tourette's syndrome evaluated with 99mTc TRODAT-1 imaging.

  2007cited by this paper
• The mesolimbic dopamine system: the final common pathway for the reinforcing effect of drugs of abuse?

  2006cited by this paper
• A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol.

  2006cited by this paper
• Neuroimaging studies of brain corpus striatum changes among heroin‐dependent patients treated with herbal medicine, U'finer ™ capsule

  2005influential reference
• Nicotinic Receptor Modulation of Dopamine Transporter Function in Rat Striatum and Medial Prefrontal Cortex

  2004cited by this paper
• Sex differences in [123I]β‐CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers

  2001cited by this paper
• Striatal Dopaminergic and Serotonergic Markers in Human Heroin Users

  2001influential reference
• Methamphetamine-related psychiatric symptoms and reduced brain dopamine transporters studied with PET.

  2001cited by this paper
• Association of dopamine transporter reduction with psychomotor impairment in methamphetamine abusers.

  2001cited by this paper
• Kappa opioid agonists alter dopamine markers and cocaine‐stimulated locomotor activity

  2001cited by this paper
• Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers

  2000cited by this paper
• Society for the study of addiction.

  1999cited by this paper
• Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis.

  1998influential reference
• Striatal presynaptic dopamine function in type 1 alcoholics measured with positron emission tomography

  1998cited by this paper
• [99mTc]TRODAT-1: A novel technetium-99m complex as a dopamine transporter imaging agent

  1997cited by this paper
• Pharmacological effects of dopaminergic drugs on in vivo binding of [99mTc]TRODAT-1 to the central dopamine transporters in rats

  1997cited by this paper
• Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra

  1997cited by this paper
• Chronic morphine induces visible changes in the morphology of mesolimbic dopamine neurons.

  1996cited by this paper
• Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections.

  1996cited by this paper
• Chronic morphine impairs axoplasmic transport in the rat mesolimbic dopamine system

  1993cited by this paper
• Wisconsin Card Sorting Test Manual – Revised and Expanded

  1993cited by this paper

• Intermittent access to oxycodone decreases dopamine uptake in the nucleus accumbens core during abstinence

  2022cites this paper
• The Legacy of the TTASAAN Report—Premature Conclusions and Forgotten Promises: A Review of Policy and Practice Part I

  2022cites this paper
• Dopaminergic and glutamatergic biomarkers disruption in addiction and regulation by exercise: a mini review

  2022cites this paper
• Effects of Medication-Assisted Treatment (MAT) for Opioid Use Disorder on Functional Outcomes: A Systematic Review.

  2020cites this paper
• Abnormalities of Neurotransmission in Drug Addiction

  2020cites this paper
• Dopamine transporter availability in alcohol and opioid dependent subjects - a 99mTc-TRODAT-1SPECT imaging and genetic association study.

  2020cites this paper
• Visual and Auditory Reaction Times of Patients with Opioid Use Disorder

  2019cites this paper
• Allostatic Changes in the cAMP System Drive Opioid-Induced Adaptation in Striatal Dopamine Signaling

  2019cites this paper
• Neuroplastic and cognitive impairment in substance use disorders: a therapeutic potential of cognitive stimulation.

  2019cites this paper
• Effect of Aldehyde Dehydrogenase 2 Gene Polymorphism on Executive Function in Opiate User

  2018cites this paper
• Comparison of striatal dopamine transporter levels in chronic heroin‐dependent and methamphetamine‐dependent subjects

  2017cites this paper
• The relationship between the striatal dopamine transporter and novelty seeking and cognitive flexibility in opioid dependence

  2017cites this paper
• The Role of Working Memory for Cognitive Control in Anorexia Nervosa versus Substance Use Disorder

  2017cites this paper
• Availability of dopamine transporters in heroin-dependent subjects: A 18F-FECNT PET imaging study.

  2017cites this paper
• Probabilistic reward- and punishment-based learning in opioid addiction: Experimental and computational data.

  2016cites this paper
• Investigating the transcriptional correlates of cognition in the heterozygous HdhQ150 mouse model of Huntington's disease

  2016cites this paper
• Decision-making ability in current and past users of opiates: A meta-analysis.

  2016cites this paper
• Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients

  2015cites this paper
• Longitudinal changes of dopamine transporters in heroin users during abstinence

  2015cites this paper